WebThis Fourth Amended and Restated Investors’ Rights Agreement dated as of November 7, 2011 (this “Agreement”), is made by and among BIND Biosciences, Inc., a Delaware corporation (the “Company”); the persons and entities listed on Schedule A (each a “Purchaser,” and collectively, the “Purchasers”); the persons and entities listed on … WebJun 7, 2012 · BIND-014 is based on BIND Biosciences' Accurin platform, originally developed by nanomedicine pioneer Robert Langer, of the Massachusetts Institute of Technology (MIT), in Cambridge, Massachusetts ...

Nanotechnology: Carrying drugs Nature

WebApr 3, 2013 · BIND—which yesterday changed its name from BIND Biosciences and named oncology veteran Gregory I. Berk, M.D. as CMO—was founded on technologies developed by Robert Langer, Sc.D., David H. Koch ... mayfair ames ia

168 Synonyms & Antonyms of BIND - Merriam Webster

WebCAMBRIDGE, MA – November 27, 2007 – BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing “smart” therapeutic targeted nanoparticles … WebJan 11, 2010 · BIND Biosciences, Inc. is a biopharmaceutical company leveraging its proprietary Medicinal Nanoengineering™ platform to produce best in class drugs. BIND’s platform enables the design, engineering and manufacturing of therapeutic targeted nanoparticles with unprecedented control over drug PK; biodistribution; cell- or tissue … WebJun 29, 2010 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based … herso proyectos